| Filing | Description | Date Filed  |
Size | ||||
|---|---|---|---|---|---|---|---|
| 8-K | current report | Jul 22, 2010 | 55.4 KB | ||||
| 8-K | current report | Jul 6, 2010 | 17.7 KB | ||||
| 4 | levine, arnold j | Jun 17, 2010 | 19.5 KB | ||||
| 4 | brinkley, david l | Jun 16, 2010 | 22.6 KB | ||||
| 8-K/A | amended current report | Jun 8, 2010 | 24.4 KB | ||||
| 4 | winningham, rick e | May 21, 2010 | 18.7 KB | ||||
| 4 | shafer, bradford j | May 21, 2010 | 21.0 KB | ||||
| 4 | mammen, mathai | May 21, 2010 | 18.8 KB | ||||
| 4 | brinkley, david l | May 21, 2010 | 18.7 KB | ||||
| 4 | blum, leonard m | May 21, 2010 | 18.8 KB | ||||
| 4 | aguiar, michael w | May 21, 2010 | 18.8 KB | ||||
| 8-K | current report | May 19, 2010 | 91.5 KB | ||||
| 8-K | current report | May 18, 2010 | 150.2 KB | ||||
| SC 13G/A | amended statement of beneficial ownership | May 10, 2010 | 26.6 KB | ||||
| S-8 | registration statement | May 5, 2010 | 67.6 KB | ||||
| 10-Q | quarterly report | May 5, 2010 | 634.0 KB | ||||
| 8-K | current report | Apr 30, 2010 | 22.6 KB | ||||
| 4 | ringrose, peter s | Apr 28, 2010 | 18.5 KB | ||||
| 3 | ringrose peter s | Apr 28, 2010 | 22.4 KB | ||||
| 4 | young, william d | Apr 28, 2010 | 19.8 KB | ||||
|
|||||||
VIBATIV is a trademark of Astellas Pharma Inc.
RELOVAIR is a trademark of Glaxo Group Limited. Mark is intended for U.S. and subject to FDA approval.
Terms of Use Website Admin Contact Theravance Contact Site Map